139 related articles for article (PubMed ID: 7521600)
1. Induction of protective immunity using minigenes.
Whitton JL
Ann N Y Acad Sci; 1994 Aug; 730():107-17. PubMed ID: 7521600
[No Abstract] [Full Text] [Related]
2. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
[TBL] [Abstract][Full Text] [Related]
3. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.
An LL; Whitton JL
J Virol; 1997 Mar; 71(3):2292-302. PubMed ID: 9032365
[TBL] [Abstract][Full Text] [Related]
4. Induction of protective cytotoxic T cells with viral proteins.
Bachmann MF; Kündig TM; Freer G; Li Y; Kang CY; Bishop DH; Hengartner H; Zinkernagel RM
Eur J Immunol; 1994 Sep; 24(9):2228-36. PubMed ID: 8088338
[TBL] [Abstract][Full Text] [Related]
5. Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.
Aichele P; Hengartner H; Zinkernagel RM; Schulz M
J Exp Med; 1990 May; 171(5):1815-20. PubMed ID: 1692084
[TBL] [Abstract][Full Text] [Related]
6. Peptide-induced antiviral protection by cytotoxic T cells.
Schulz M; Zinkernagel RM; Hengartner H
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):991-3. PubMed ID: 1992491
[TBL] [Abstract][Full Text] [Related]
7. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge.
Whitton JL; Sheng N; Oldstone MB; McKee TA
J Virol; 1993 Jan; 67(1):348-52. PubMed ID: 7677954
[TBL] [Abstract][Full Text] [Related]
8. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.
van der Most RG; Murali-Krishna K; Whitton JL; Oseroff C; Alexander J; Southwood S; Sidney J; Chesnut RW; Sette A; Ahmed R
Virology; 1998 Jan; 240(1):158-67. PubMed ID: 9448700
[TBL] [Abstract][Full Text] [Related]
9. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
Storni T; Lechner F; Erdmann I; Bächi T; Jegerlehner A; Dumrese T; Kündig TM; Ruedl C; Bachmann MF
J Immunol; 2002 Mar; 168(6):2880-6. PubMed ID: 11884458
[TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility complex--dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease.
Schulz M; Aichele P; Vollenweider M; Bobe FW; Cardinaux F; Hengartner H; Zinkernagel RM
Eur J Immunol; 1989 Sep; 19(9):1657-67. PubMed ID: 2477254
[TBL] [Abstract][Full Text] [Related]
11. Vaccination to prevent persistent viral infection.
Oldstone MB; Tishon A; Eddleston M; de la Torre JC; McKee T; Whitton JL
J Virol; 1993 Jul; 67(7):4372-8. PubMed ID: 8510226
[TBL] [Abstract][Full Text] [Related]
12. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.
Sedlik C; Dadaglio G; Saron MF; Deriaud E; Rojas M; Casal SI; Leclerc C
J Virol; 2000 Jul; 74(13):5769-75. PubMed ID: 10846055
[TBL] [Abstract][Full Text] [Related]
13. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein.
Zarozinski CC; Fynan EF; Selin LK; Robinson HL; Welsh RM
J Immunol; 1995 Apr; 154(8):4010-7. PubMed ID: 7706740
[TBL] [Abstract][Full Text] [Related]
14. Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes.
Ciupitu AM; Petersson M; O'Donnell CL; Williams K; Jindal S; Kiessling R; Welsh RM
J Exp Med; 1998 Mar; 187(5):685-91. PubMed ID: 9480978
[TBL] [Abstract][Full Text] [Related]
15. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
[TBL] [Abstract][Full Text] [Related]
16. Protection against CTL escape and clinical disease in a murine model of virus persistence.
Kim TS; Perlman S
J Immunol; 2003 Aug; 171(4):2006-13. PubMed ID: 12902505
[TBL] [Abstract][Full Text] [Related]
17. [Repertoire of epitopes of human immunodeficiency virus proteins and the search for vaccines and diagnostic kits].
Kharchenko EP; Klimenko AP
Dokl Akad Nauk SSSR; 1992; 322(1):189-92. PubMed ID: 1380907
[No Abstract] [Full Text] [Related]
18. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
19. Attenuated Mengo virus: a new vector for live recombinant vaccines.
Altmeyer R; Girard M; van der Werf S; Mimic V; Seigneur L; Saron MF
J Virol; 1995 May; 69(5):3193-6. PubMed ID: 7707549
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T-lymphocyte epitopes fused to anthrax toxin induce protective antiviral immunity.
Doling AM; Ballard JD; Shen H; Krishna KM; Ahmed R; Collier RJ; Starnbach MN
Infect Immun; 1999 Jul; 67(7):3290-6. PubMed ID: 10377103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]